Patrick Walsh

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Prostatectomy 97%
3. Prostate 42%
4. Prostate-Specific Antigen 41%
5. Familial Prostate cancer 30%
6. Neoplasm Grading 21%
7. Neoplasms 19%
8. Prostatic Hyperplasia 17%
9. Recurrence 16%
10. Androgens 12%
11. Needle Biopsy 11%
12. Carcinoma 11%
13. Adenocarcinoma 10%
14. Survival 10%
15. Margins of Excision 9%
16. Single Nucleotide Polymorphism 9%
17. Biopsy 9%
18. Lymph Nodes 9%
19. Androgen Receptors 9%
20. Neoplasm Metastasis 8%
21. Testosterone 8%
22. Serum 8%
23. Hypogastric Plexus 7%
24. Testis 7%
25. Neoplasm Genes 6%
26. Genes 6%
27. Tumor Burden 6%
28. Dihydrotestosterone 6%
29. Therapeutics 5%
30. Watchful Waiting 5%
31. Germ-Line Mutation 5%
32. Radiotherapy 5%
33. Finasteride 5%
34. Luteinizing Hormone 5%